Else Establishes Its Own Manufacturing Capacity in Oregon U.S.A.
January 18 2022 - 7:00AM
ELSE NUTRITION HOLDINGS INC.
(BABY.V)
(BABYF)
(0YL.F) ("Else" or the
"Company") the Plant-Based baby, toddler and
children nutrition company, today announced that is has signed an
agreement to establish a specialized manufacturing site to process
and prepare Else’s proprietary specialized, demineralized buckwheat
for its infant formula.
The Company completed the development of its
unique production process for the demineralized buckwheat and
anticipates producing the first batch of specially processed
buckwheat in Q1 2022. The new facility output will support the
infant formula production expected during the first years. The
buckwheat will be processed under the strictest quality controls
and standards without the use of chemicals or solvents. Else’s
proprietary process uses all natural processes and maintains the
natural chemical composition of the ingredient intact (protein,
carbs, fats…etc.).
“This is a great step in our quest for plant
based clean label infant nutrition, since buckwheat is a key
ingredient in our infant formula, and nowhere else in the world is
it processed in such a way,” said Hamutal Yitzhak, CEO &
Co-Founder of Else Nutrition.
“This is a very encouraging development along
our manufacturing pathway as we look ahead to launching a real and
first Plant-Based, Clean label Dairy-free and Soy-free, minimally
processed infant formula in the market.”
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food
and nutrition company focused on developing innovative, clean and
plant-based food and nutrition products for infants, toddlers,
children, and adults. Its revolutionary, plant-based, non-soy,
formula is a clean-ingredient alternative to dairy-based formula.
Else Nutrition (formerly INDI) won the "2017 Best Health and Diet
Solutions" award at the Global Food Innovation Summit in Milan.
Else Plant-Based Complete Nutrition for Toddlers was recently
ranked as the #1 Top seller in the baby and toddler formula
category on Amazon. The Company recently received the World
Plant-Based Award for “Best dairy alternative product” in New York
at World Plant-Based Expo in late 2021. The holding company, Else
Nutrition Holdings Inc., is a publicly traded company, listed as
TSX Venture Exchange under the trading symbol BABY and is quoted on
the US OTC Markets QX board under the trading symbol BABYF and on
the Frankfurt Exchange under the symbol 0YL. Else's Executives
includes leaders hailing from leading infant nutrition
companies. Many of Else advisory board members had past executive
roles in companies such as Mead Johnson, Abbott Nutrition, Plum
Organics and leading infant nutrition Societies, and some of them
currently serve in different roles in leading medical centers and
academic institutes such as Boston Children's Hospital, Pediatrics
at Harvard Medical School, USA, Tel Aviv University, Schneider
Children's Medical Center of Israel, Rambam Medical Center and
Technion, Israel and University Hospital Brussels, Belgium.
For more information,
visit: elsenutrition.com or @elsenutrition on Facebook
and Instagram.
Lytham Partners, LLCMr. Ben ShamsianNew York |
PhoenixE: shamsian@lythampartners.comP: 646-829-9701
TSX Venture Exchange
Neither the TSX Venture Exchange nor its
regulation services provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Caution Regarding Forward-Looking
Statements
This press release contains statements that may
constitute “forward-looking statements” within the meaning of
applicable securities legislation. Forward-looking statements are
typically identified by words such as “will” or similar
expressions. Forward-looking statements in this press release
include statements with respect to the anticipated dates for filing
the Company’s financial disclosure documents. Such forward-looking
statements reflect current estimates, beliefs and assumptions,
which are based on management’s perception of current conditions
and expected future developments, as well as other factors
management believes are appropriate in the circumstances. No
assurance can be given that the foregoing will prove to be correct.
Forward-looking statements made in this press release assume, among
others, the expectation that there will be no interruptions or
supply chain failures as a result of COVID 19 and that the
manufacturing, broker and supply logistic agreement with the
Company do not terminate. Actual results may differ from the
estimates, beliefs and assumptions expressed or implied in the
forward-looking statements. Readers are cautioned not to place
undue reliance on any forward-looking statements, which reflect
management’s expectations only as of the date of this press
release. The Company disclaims any obligation to update or revise
any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
law.
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/045fc0e9-4911-467b-b00a-9f1f4687c494
Else Nutrition (TSXV:BABY)
Historical Stock Chart
From Sep 2024 to Oct 2024
Else Nutrition (TSXV:BABY)
Historical Stock Chart
From Oct 2023 to Oct 2024